These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35864548)

  • 1. Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients.
    Yu H; Lv W; Tan Y; He X; Wu Y; Wu M; Zhang Q
    J Transl Med; 2022 Jul; 20(1):328. PubMed ID: 35864548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
    Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
    J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
    Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
    Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
    Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.
    Fu X; Yang Y; Zhang X
    Front Genet; 2022; 13():919599. PubMed ID: 36134033
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer.
    Wang Z; Wu P; Shi J; Ji X; He L; Dong W; Wang Z; Zhang H; Sun W
    Front Genet; 2022; 13():947216. PubMed ID: 36186479
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
    Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
    Front Immunol; 2022; 13():999084. PubMed ID: 36544770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
    Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
    BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
    Peng YL; Wang LX; Li MY; Liu LP; Li RS
    PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
    He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y
    Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.
    Zhang F; Qi C; Yao Z; Xu H; Zhou G; Li C; Xia H
    Apoptosis; 2023 Dec; 28(11-12):1628-1645. PubMed ID: 37787960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer.
    Xu Y; Zheng Q; Zhou T; Ye B; Xu Q; Meng X
    Front Oncol; 2022; 12():887318. PubMed ID: 35686108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
    Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
    J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment.
    Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B
    Front Genet; 2022; 13():917007. PubMed ID: 35899194
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel necroptosis signature for predicting survival in lung adenocarcinoma.
    Zang K; Wang M; Zhu X; Yao B; Huang Y
    BMC Med Genomics; 2023 Nov; 16(1):305. PubMed ID: 38017445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.